|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
13.11.26 - 04:15
|
JD HEALTH Signs Strategic Cooperation Agreement With PIENTZEHUANG (AAStocks)
|
|
|
JD HEALTH (06618.HK) signed a strategic cooperation agreement with PIENTZEHUANG (600436.SH). The two parties will fully leverage PIENTZEHUANG's advantages in products, industry and branding, as well as JD HEALTH's capabilities in platform connectivity, user operations, digital intelligent supply chain and omni-channel operations......
|
|
|
|
|
|
|
|
|
|
|
|
|
14.08.26 - 04:30
|
Research: CLSA Cuts JD HEALTH TP to HKD61, 1H Results In Line (AAStocks)
|
|
|
CLSA issued a report saying that JD HEALTH (06618.HK)'s results for the first half were in line with expectations. Revenue rose 15.9% YoY, while adjusted EBIT increased 40% YoY. Second-quarter revenue grew 14.9% YoY, slowing from the 17% YoY growth in the first quarter, with strong pharmaceutical sales but weaker sales of nutrit......
|
|
|
|
|
|
|
|
|
13.08.26 - 06:00
|
JD HEALTH Forges Deepened Co-op with Dermatology Drugmaker LEO Pharma (AAStocks)
|
|
|
JD HEALTH (06618.HK) announced multiple cooperation agreements with dermatology pharmaceutical company LEO Pharma on topics including first launches of new drugs, AI-powered digital marketing innovation, chronic disease patient management, deep supply chain collaboration and long-term brand building. Based on a "patient-cen......
|
|
|
|
|
|
|
29.06.26 - 04:45
|
JD HEALTH Spends HKD16M+ to Buy Back 500,000 Shares (AAStocks)
|
|
|
JD HEALTH (06618.HK) repurchased a total of 500,000 shares of the company on the Hong Kong Stock Exchange on June 26, at prices ranging from HKD31.84 to HKD32.68 per share, involving HKD16.0247 million, disclosure filings showed. Since the repurchase mandate was approved, the group has cumulatively bought back 20.9424 million sh......
|
|